Hanyu Chu, Lijie Zhou, Yanzhen Mao, Ren Liu, Jiaojiao Han, Xiurong Su, Jun Zhou
Lacticaseibacillus rhamnosus (L. rhamnosus) is a safe probiotic with no side effects, providing benefits such as gut microbiota regulation and immune enhancement, making it highly valuable with strong potential. However, strains from different sources have unique traits, and whole-genome sequencing (WGS) helps analyse these differences. In this study, we used WGS to examine L. rhamnosus strains from mice with fish oil-treated smoking-induced pneumonia to better understand their biological functions and explore possible anti-inflammatory mechanisms.
Methods: We isolated a strain, Lacticaseibacillus rhamnosus CP-1 (L. rhamnosus CP-1), from mice intestines where fish oil alleviated smoking-induced pneumonia. Identification of probiotic-related genes by WGS and characterised the strain's probiotic properties.
Results: L. rhamnosus CP-1 has a single circular chromosome (2,989,570 bp, 46.76% GC content) and no plasmids. COG, GO, and KEGG databases revealed genes linked to carbohydrate metabolism. The CAZy database identified GH25 lysozyme and PL8 polysaccharide lyase genes. KEGG highlighted an antimicrobial peptide ABC transporter permease, while TCDB noted the ABC-type antimicrobial peptide transporter (the main active transport component). KEGG also showed 10 genes for terpenoid skeleton biosynthesis and 5 for keto-glycan unit biosynthesis. Additionally, L. rhamnosus CP-1 carries metabolic regulators and bacteriocin-related genes.
Conclusions: Whole-genome sequencing analysis revealed that L. rhamnosus CP-1 has carbohydrate utilisation and potential anti-inflammatory effects at the molecular level. Potential functional genes include carbohydrate transport and hydrolase, antimicrobial peptide ABC transporter and its osmotic enzyme components, bacteriocin immune protein, terpenoid skeleton, and keto-glycan synthesis.
鼠李糖乳杆菌(lactoaseibacillus rhamnosus, L. rhamnosus)是一种安全无副作用的益生菌,具有调节肠道菌群、增强免疫力等功效,价值极高,潜力巨大。然而,来自不同来源的菌株具有独特的性状,全基因组测序(WGS)有助于分析这些差异。在本研究中,我们使用WGS检测了来自鱼油处理的吸烟性肺炎小鼠的鼠李糖乳杆菌菌株,以更好地了解其生物学功能并探索可能的抗炎机制。方法:从鼠李糖乳杆菌CP-1 (L. rhamnosus CP-1)小鼠肠道中分离出一株鱼油对吸烟性肺炎的缓解作用。利用WGS鉴定益生菌相关基因,并对菌株的益生菌特性进行了表征。结果:鼠李糖CP-1染色体为单条环状染色体(2,989,570 bp, GC含量46.76%),无质粒。COG、GO和KEGG数据库揭示了与碳水化合物代谢相关的基因。CAZy数据库鉴定出GH25溶菌酶和PL8多糖裂解酶基因。KEGG强调了抗菌肽ABC转运体渗透酶,而TCDB则强调了ABC型抗菌肽转运体(主要的活性转运成分)。KEGG还发现了10个萜类骨架生物合成基因和5个酮聚糖单位生物合成基因。此外,鼠李糖CP-1携带代谢调节因子和细菌素相关基因。结论:全基因组测序分析显示鼠李糖多糖CP-1在分子水平上具有碳水化合物利用和潜在的抗炎作用。潜在的功能基因包括碳水化合物转运和水解酶、抗菌肽ABC转运蛋白及其渗透酶组分、细菌素免疫蛋白、萜类骨架和酮聚糖合成。
{"title":"Anti-Inflammatory Function Analysis of <i>Lacticaseibacillus rhamnosus</i> CP-1 Strain Based on Whole-Genome Sequencing.","authors":"Hanyu Chu, Lijie Zhou, Yanzhen Mao, Ren Liu, Jiaojiao Han, Xiurong Su, Jun Zhou","doi":"10.3390/biotech14020047","DOIUrl":"10.3390/biotech14020047","url":null,"abstract":"<p><p><i>Lacticaseibacillus rhamnosus</i> (<i>L. rhamnosus</i>) is a safe probiotic with no side effects, providing benefits such as gut microbiota regulation and immune enhancement, making it highly valuable with strong potential. However, strains from different sources have unique traits, and whole-genome sequencing (WGS) helps analyse these differences. In this study, we used WGS to examine <i>L. rhamnosus</i> strains from mice with fish oil-treated smoking-induced pneumonia to better understand their biological functions and explore possible anti-inflammatory mechanisms.</p><p><strong>Methods: </strong>We isolated a strain, <i>Lacticaseibacillus rhamnosus</i> CP-1 (<i>L. rhamnosus</i> CP-1), from mice intestines where fish oil alleviated smoking-induced pneumonia. Identification of probiotic-related genes by WGS and characterised the strain's probiotic properties.</p><p><strong>Results: </strong><i>L. rhamnosus</i> CP-1 has a single circular chromosome (2,989,570 bp, 46.76% GC content) and no plasmids. COG, GO, and KEGG databases revealed genes linked to carbohydrate metabolism. The CAZy database identified GH25 lysozyme and PL8 polysaccharide lyase genes. KEGG highlighted an antimicrobial peptide ABC transporter permease, while TCDB noted the ABC-type antimicrobial peptide transporter (the main active transport component). KEGG also showed 10 genes for terpenoid skeleton biosynthesis and 5 for keto-glycan unit biosynthesis. Additionally, <i>L. rhamnosus</i> CP-1 carries metabolic regulators and bacteriocin-related genes.</p><p><strong>Conclusions: </strong>Whole-genome sequencing analysis revealed that <i>L. rhamnosus</i> CP-1 has carbohydrate utilisation and potential anti-inflammatory effects at the molecular level. Potential functional genes include carbohydrate transport and hydrolase, antimicrobial peptide ABC transporter and its osmotic enzyme components, bacteriocin immune protein, terpenoid skeleton, and keto-glycan synthesis.</p>","PeriodicalId":34490,"journal":{"name":"BioTech","volume":"14 2","pages":""},"PeriodicalIF":2.7,"publicationDate":"2025-06-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12190639/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144486335","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
José Luis Aguirre-Noyola, Marco A Ramírez-Mosqueda, Jorge David Cadena-Zamudio, José Humberto Caamal-Velázquez, Esmeralda J Cruz-Gutiérrez, Alma Armenta-Medina
Nanobiotechnology applications in plant tissue culture have improved the development and physiology of explants, resulting in plants with high genetic homogeneity and phytosanitary quality. Silver nanoparticles (AgNPs) are well-known for their microbicidal properties, but their biochemical effects on plants require further exploration. In this work, green-synthesized AgNPs were evaluated in strawberry in vitro culture, photosynthetic pigment production, and acclimatization. AgNPs produced by Lysinibacillus fusiformis were characterized. Strawberry explants were grown in vitro on MS medium with 0, 100, 200, and 300 mg L-1 AgNPs at 24 ± 2 °C and a photoperiod of 16:8 h light/dark. Shoot height and number, number of leaves, number of roots, and root length were evaluated, and chlorophyll (a, b, and total) was quantified. Rooted shoots were acclimatized ex vitro on substrates containing 0 and 200 mg L-1 AgNPs. The results showed that low AgNPs concentrations had a positive impact on shoot multiplication, development, and rooting, but at higher concentrations, the effects decayed. However, chlorophyll production improved with increasing AgNP concentration. Shoots treated with AgNPs showed higher ex vitro survival. Our study has direct implications for the profitability and sustainability of commercial strawberry production.
{"title":"Green-Synthesized Silver Nanoparticles (AgNPs) Enhance In Vitro Multiplication and Rooting of Strawberries (<i>Fragaria</i> × <i>ananassa</i> Duchesne).","authors":"José Luis Aguirre-Noyola, Marco A Ramírez-Mosqueda, Jorge David Cadena-Zamudio, José Humberto Caamal-Velázquez, Esmeralda J Cruz-Gutiérrez, Alma Armenta-Medina","doi":"10.3390/biotech14020045","DOIUrl":"10.3390/biotech14020045","url":null,"abstract":"<p><p>Nanobiotechnology applications in plant tissue culture have improved the development and physiology of explants, resulting in plants with high genetic homogeneity and phytosanitary quality. Silver nanoparticles (AgNPs) are well-known for their microbicidal properties, but their biochemical effects on plants require further exploration. In this work, green-synthesized AgNPs were evaluated in strawberry in vitro culture, photosynthetic pigment production, and acclimatization. AgNPs produced by <i>Lysinibacillus fusiformis</i> were characterized. Strawberry explants were grown in vitro on MS medium with 0, 100, 200, and 300 mg L<sup>-1</sup> AgNPs at 24 ± 2 °C and a photoperiod of 16:8 h light/dark. Shoot height and number, number of leaves, number of roots, and root length were evaluated, and chlorophyll (a, b, and total) was quantified. Rooted shoots were acclimatized ex vitro on substrates containing 0 and 200 mg L<sup>-1</sup> AgNPs. The results showed that low AgNPs concentrations had a positive impact on shoot multiplication, development, and rooting, but at higher concentrations, the effects decayed. However, chlorophyll production improved with increasing AgNP concentration. Shoots treated with AgNPs showed higher ex vitro survival. Our study has direct implications for the profitability and sustainability of commercial strawberry production.</p>","PeriodicalId":34490,"journal":{"name":"BioTech","volume":"14 2","pages":""},"PeriodicalIF":2.7,"publicationDate":"2025-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12191388/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144486338","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Microalgae represent promising biotechnological platforms for bioactive compound production with pharmaceutical applications. This study investigated the phytochemical composition and biological activities of lipid extracts from three Chlorella species to evaluate their potential as antioxidant and antidiabetic sources. Lipid extraction using chloroform-methanol (2:1) followed by GC-MS analysis revealed distinct compound distributions: 29 compounds in C. ellipsoidea, 33 in C. sorokiniana, and 19 in C. vulgaris. Major bioactive compounds included 2-hexanol, 1,3,6-heptatriene, 4-(2,3-dimethyl-2-cyclopenten-1-yl)-4-methylpentanal, n-hexadecanoic acid, and octadecanoic acid. Biological activity screening encompassed antioxidant assessment through DPPH• and •NO radical scavenging assays and FRAP analysis, while antidiabetic potential was evaluated using α-glucosidase and α-amylase inhibition assays. C. sorokiniana exhibited superior bioactivity with the highest antioxidant capacity (DPPH• IC50 = 329.03 ± 4.30 µg/mL; •NO IC50 = 435.53 ± 10.20 µg/mL; FRAP = 94.74 ± 5.72 mg TE/g) and strongest enzyme inhibition (α-glucosidase IC50 = 752.75 ± 57.95 µg/mL; α-amylase IC50 = 3458.50 ± 104.01 µg/mL). This is the first report on C. sorokiniana strain KU.B2's biological properties and phytochemical profile. These findings establish C. sorokiniana as a valuable biotechnological platform for pharmaceutical bioactive compound development.
{"title":"In Vitro Antioxidant Potential, Antidiabetic Activities, and GC-MS Analysis of Lipid Extracts of <i>Chlorella</i> Microalgae.","authors":"Somruthai Kaeoboon, Rattanaporn Songserm, Rungcharn Suksungworn, Sutsawat Duangsrisai, Nuttha Sanevas","doi":"10.3390/biotech14020046","DOIUrl":"10.3390/biotech14020046","url":null,"abstract":"<p><p>Microalgae represent promising biotechnological platforms for bioactive compound production with pharmaceutical applications. This study investigated the phytochemical composition and biological activities of lipid extracts from three <i>Chlorella</i> species to evaluate their potential as antioxidant and antidiabetic sources. Lipid extraction using chloroform-methanol (2:1) followed by GC-MS analysis revealed distinct compound distributions: 29 compounds in <i>C. ellipsoidea</i>, 33 in <i>C. sorokiniana</i>, and 19 in <i>C. vulgaris</i>. Major bioactive compounds included 2-hexanol, 1,3,6-heptatriene, 4-(2,3-dimethyl-2-cyclopenten-1-yl)-4-methylpentanal, <i>n</i>-hexadecanoic acid, and octadecanoic acid. Biological activity screening encompassed antioxidant assessment through DPPH• and •NO radical scavenging assays and FRAP analysis, while antidiabetic potential was evaluated using α-glucosidase and α-amylase inhibition assays. <i>C. sorokiniana</i> exhibited superior bioactivity with the highest antioxidant capacity (DPPH• IC<sub>50</sub> = 329.03 ± 4.30 µg/mL; •NO IC<sub>50</sub> = 435.53 ± 10.20 µg/mL; FRAP = 94.74 ± 5.72 mg TE/g) and strongest enzyme inhibition (α-glucosidase IC<sub>50</sub> = 752.75 ± 57.95 µg/mL; α-amylase IC<sub>50</sub> = 3458.50 ± 104.01 µg/mL). This is the first report on <i>C. sorokiniana</i> strain KU.B2's biological properties and phytochemical profile. These findings establish <i>C. sorokiniana</i> as a valuable biotechnological platform for pharmaceutical bioactive compound development.</p>","PeriodicalId":34490,"journal":{"name":"BioTech","volume":"14 2","pages":""},"PeriodicalIF":2.7,"publicationDate":"2025-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12190495/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144486339","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Venturia inaequalis, the cause of apple scab, readily develops resistance to fungicides with specific modes of action. Knowledge of the spatial and temporal pattern of resistance development is therefore relevant to fruit producers and their consultants. In the Lower Elbe region of Northern Germany, a two-year survey based on a conidial germination test was conducted, examining fungicide resistance in 35 orchards under Integrated Pest Management (IPM), 16 orchards of susceptible cultivars as well as a further 12 orchards of scab-resistant (Vf) cultivars under organic management, and 34 abandoned or unmanaged sites. No evidence of resistance to SDHI compounds (fluopyram, fluxapyroxad) was found after >5 yr of their regular use. Resistance to anilinopyrimidines (cyprodinil, pyrimethanil) had disappeared 15 yr after its widespread occurrence. Isolates from a few IPM orchards showed a reduced sensitivity to dodine. Double resistance to the MBC compound thiophanate-methyl and the QoI trifloxystrobin was rare in V. inaequalis strains that had achieved breakage of Vf-resistance, but very common (>50%) on scab-susceptible cultivars in IPM, organic and abandoned orchards in the 'Altes Land' core area of the Lower Elbe region, and in IPM orchards in the periphery. We conclude that resistance to QoI and MBC fungicides is persistent even decades after their last use, and that the core area harbours a uniform population adapted to intensive crop protection, whereas isolated orchards in the periphery are colonised by discrete populations of V. inaequalis.
{"title":"Spatial and Temporal Aspects of Fungicide Resistance in <i>Venturia inaequalis</i> (Apple Scab) Populations in Northern Germany.","authors":"Roland W S Weber, Rebekka Busch, Johanna Wesche","doi":"10.3390/biotech14020044","DOIUrl":"10.3390/biotech14020044","url":null,"abstract":"<p><p><i>Venturia inaequalis</i>, the cause of apple scab, readily develops resistance to fungicides with specific modes of action. Knowledge of the spatial and temporal pattern of resistance development is therefore relevant to fruit producers and their consultants. In the Lower Elbe region of Northern Germany, a two-year survey based on a conidial germination test was conducted, examining fungicide resistance in 35 orchards under Integrated Pest Management (IPM), 16 orchards of susceptible cultivars as well as a further 12 orchards of scab-resistant (<i>Vf</i>) cultivars under organic management, and 34 abandoned or unmanaged sites. No evidence of resistance to SDHI compounds (fluopyram, fluxapyroxad) was found after >5 yr of their regular use. Resistance to anilinopyrimidines (cyprodinil, pyrimethanil) had disappeared 15 yr after its widespread occurrence. Isolates from a few IPM orchards showed a reduced sensitivity to dodine. Double resistance to the MBC compound thiophanate-methyl and the QoI trifloxystrobin was rare in <i>V. inaequalis</i> strains that had achieved breakage of <i>Vf</i>-resistance, but very common (>50%) on scab-susceptible cultivars in IPM, organic and abandoned orchards in the 'Altes Land' core area of the Lower Elbe region, and in IPM orchards in the periphery. We conclude that resistance to QoI and MBC fungicides is persistent even decades after their last use, and that the core area harbours a uniform population adapted to intensive crop protection, whereas isolated orchards in the periphery are colonised by discrete populations of <i>V. inaequalis</i>.</p>","PeriodicalId":34490,"journal":{"name":"BioTech","volume":"14 2","pages":""},"PeriodicalIF":2.7,"publicationDate":"2025-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12190306/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144486343","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Investigating the functional interactions between rumen microbial fermentation and epithelial mitochondrial dynamics/energy metabolism in Tibetan sheep at different altitudes, this study examined ultrastructural changes in rumen epithelial tissues, expression levels of mitochondrial dynamics-related genes (fusion: Mfn1, Mfn2, OPA1, Mic60; fission: Drp1, Fis1, MFF), and ketogenesis pathway genes (HMGS2, HMGCL) in Tibetan sheep raised at three altitudes (TS 2500m, TS 3500m, TS 4500m). Correlation analysis was performed between rumen microbiota/metabolites and mitochondrial energy metabolism. Results: Ultrastructural variations were observed across altitudes. With increasing altitude, keratinized layer became more compact; desmosome connections between granular layer cells increased; mitochondrial quantity and distribution in spinous and basal layers increased. Mitochondrial dynamics regulation: Fission genes (FIS1, DRP1, MFF) showed significantly higher expression at TS 4500m (p < 0.01); fusion genes (Mfn1, OPA1) exhibited altitude-dependent upregulation. Energy metabolism markers: Pyruvate (PA) decreased significantly at TS 3500m/TS 4500m (p < 0.01); citrate (CA) increased with altitude; NAD+ peaked at TS 3500m but decreased significantly at TS 4500m (p < 0.01); Complex II (SDH) and Complex IV (CO) activities decreased at TS 4500m (p < 0.01). Ketogenesis pathway: β-hydroxybutyrate increased significantly with altitude (p < 0.01); acetoacetate peaked at TS 2500 m/TS 4500 m; HMGCS2 expression exceeded HMGCL, showing altitude-dependent upregulation at TS 4500m (p < 0.01). Microbiome-metabolism correlations: Butyrivibrio_2 and Fibrobacter negatively correlated with Mic60 (p < 0.01); Ruminococcaceae_NK4A214_Group positively correlated with Mfn1/OPA1 (p < 0.05); WGCNA identified 17 metabolite modules, with MEturquoise module positively correlated with DRP1/Mfn2/MFF (p < 0.05). Conclusion: Altitude-induced ultrastructural adaptations in rumen epithelium correlate with mitochondrial dynamics stability and ketogenesis upregulation. Mitochondrial fission predominates at extreme altitudes, while microbiota-metabolite interactions suggest compensatory energy regulation mechanisms.
The emergence of antimicrobial resistance (AMR) in Clostridium difficile (C. difficile), particularly to last-line antibiotics such as linezolid, represents a critical challenge in clinical settings. This study investigates the genomic epidemiology of linezolid-resistant C. difficile, focusing on the distribution and mutational patterns of the chloramphenicol-florfenicol resistance (cfr) gene and its association with multidrug resistance. We analyzed 514 clinical isolates (354 from NCBI Pathogen Detection, 160 from EnteroBase), revealing distinct prevalence patterns among cfr subtypes: cfr(C) was dominant (156/354 NCBI strains; 101/160 EnteroBase strains), whereas cfr(B) frequently harbored missense mutations (p.R247K, p.V294I, and less commonly p.A334T). The cfr(E) subtype was exclusively identified in ribotype 027 (RT027) strains. Notably, cfr(C) exhibited a strong association with RT017, correlating with a conserved 99 bp genomic deletion. Phylogenetic analysis linked cfr-carriage to predominant sequence types (ST1 in NCBI strains, ST37 in EnteroBase isolates). Furthermore, the co-occurrence of cfr with additional AMR genes conferred resistance to macrolides (erythromycin, azithromycin) and tetracyclines, indicating a convergent evolution toward multidrug resistance. These findings underscore the interplay between cfr mutations, hypervirulent ribotypes, and AMR dissemination, necessitating enhanced surveillance to mitigate the spread of resistant C. difficile lineages.
{"title":"Genomic Characterization of Linezolid-Resistant <i>Clostridioides difficile</i> Harboring <i>cfr</i> Variants.","authors":"Aikaterini Panou, Andigoni Malousi, Melina Kachrimanidou","doi":"10.3390/biotech14020042","DOIUrl":"10.3390/biotech14020042","url":null,"abstract":"<p><p>The emergence of antimicrobial resistance (AMR) in <i>Clostridium difficile</i> (<i>C. difficile</i>), particularly to last-line antibiotics such as linezolid, represents a critical challenge in clinical settings. This study investigates the genomic epidemiology of linezolid-resistant <i>C. difficile</i>, focusing on the distribution and mutational patterns of the chloramphenicol-florfenicol resistance (<i>cfr</i>) gene and its association with multidrug resistance. We analyzed 514 clinical isolates (354 from NCBI Pathogen Detection, 160 from EnteroBase), revealing distinct prevalence patterns among <i>cfr</i> subtypes: <i>cfr</i>(C) was dominant (156/354 NCBI strains; 101/160 EnteroBase strains), whereas <i>cfr</i>(B) frequently harbored missense mutations (p.R247K, p.V294I, and less commonly p.A334T). The <i>cfr</i>(E) subtype was exclusively identified in ribotype 027 (RT027) strains. Notably, <i>cfr</i>(C) exhibited a strong association with RT017, correlating with a conserved 99 bp genomic deletion. Phylogenetic analysis linked <i>cfr</i>-carriage to predominant sequence types (ST1 in NCBI strains, ST37 in EnteroBase isolates). Furthermore, the co-occurrence of <i>cfr</i> with additional AMR genes conferred resistance to macrolides (erythromycin, azithromycin) and tetracyclines, indicating a convergent evolution toward multidrug resistance. These findings underscore the interplay between <i>cfr</i> mutations, hypervirulent ribotypes, and AMR dissemination, necessitating enhanced surveillance to mitigate the spread of resistant <i>C. difficile</i> lineages.</p>","PeriodicalId":34490,"journal":{"name":"BioTech","volume":"14 2","pages":""},"PeriodicalIF":2.7,"publicationDate":"2025-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12190932/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144486337","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Sergiana Dos Passos Ramos, Monize Bürck, Stephanie Fabrícia Francisco da Costa, Marcelo Assis, Anna Rafaela Cavalcante Braga
Limnospira spp., commercially known as spirulina, is widely recognized for its remarkable benefits due to its rich composition of bioactive compounds like phycobiliproteins, carotenoids, and phenolic compounds. These natural bioactive compounds not only serve as colorants but also offer potent antioxidant, anti-inflammatory, immunomodulatory, anticancer, antimicrobial, and anti-aging properties. As a result, spirulina and its components are increasingly used in cosmetic formulations to promote skin hydration, reduce wrinkles, and protect against UV radiation damage. Its bioactive components enhance fibroblast growth, boost collagen production, and prevent premature skin aging by inhibiting enzymes responsible for elastin degradation. Additionally, spirulina-based cosmetics have demonstrated wound-healing properties without genotoxic effects, with formulations containing C-phycocyanin particularly effective in shielding skin cells from UV-induced apoptosis. Despite these well-established benefits, there remains significant potential for the cosmetic industry to harness spirulina's capabilities further. Research into the molecular mechanisms underlying its bioactive compounds in cosmetic formulations is still in its early stages, offering many opportunities for innovation. Emerging fields of biotechnology, such as nanotechnology and biocosmetics, could enhance the stability, efficacy, and delivery of spirulina-based ingredients, unlocking new possibilities for skin protection and rejuvenation. Furthermore, its proven biological properties align perfectly with the increasing consumer demand for safe, sustainable, and nature-inspired skincare solutions.
{"title":"Spirulina as a Key Ingredient in the Evolution of Eco-Friendly Cosmetics.","authors":"Sergiana Dos Passos Ramos, Monize Bürck, Stephanie Fabrícia Francisco da Costa, Marcelo Assis, Anna Rafaela Cavalcante Braga","doi":"10.3390/biotech14020041","DOIUrl":"10.3390/biotech14020041","url":null,"abstract":"<p><p><i>Limnospira</i> spp., commercially known as spirulina, is widely recognized for its remarkable benefits due to its rich composition of bioactive compounds like phycobiliproteins, carotenoids, and phenolic compounds. These natural bioactive compounds not only serve as colorants but also offer potent antioxidant, anti-inflammatory, immunomodulatory, anticancer, antimicrobial, and anti-aging properties. As a result, spirulina and its components are increasingly used in cosmetic formulations to promote skin hydration, reduce wrinkles, and protect against UV radiation damage. Its bioactive components enhance fibroblast growth, boost collagen production, and prevent premature skin aging by inhibiting enzymes responsible for elastin degradation. Additionally, spirulina-based cosmetics have demonstrated wound-healing properties without genotoxic effects, with formulations containing C-phycocyanin particularly effective in shielding skin cells from UV-induced apoptosis. Despite these well-established benefits, there remains significant potential for the cosmetic industry to harness spirulina's capabilities further. Research into the molecular mechanisms underlying its bioactive compounds in cosmetic formulations is still in its early stages, offering many opportunities for innovation. Emerging fields of biotechnology, such as nanotechnology and biocosmetics, could enhance the stability, efficacy, and delivery of spirulina-based ingredients, unlocking new possibilities for skin protection and rejuvenation. Furthermore, its proven biological properties align perfectly with the increasing consumer demand for safe, sustainable, and nature-inspired skincare solutions.</p>","PeriodicalId":34490,"journal":{"name":"BioTech","volume":"14 2","pages":""},"PeriodicalIF":2.7,"publicationDate":"2025-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12190513/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144486344","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Demosthenis Chachalis, Eleni Tani, Aliki Kapazoglou, Maria Gerakari, Angeliki Petraki, Francisco Pérez-Alfocea, Purificación A Martínez-Melgarejo, Markus Albert, Khalil Khamassi, Mohamed Kharrat
Broomrapes (Orobanche and Phelipanche spp.) are parasitic weeds that significantly impact the productivity of major crops in the Mediterranean region, like tomato (Solanum spp.) and faba bean (Vicia faba) species. This review article extensively discusses management strategies to control broomrapes, which range from preventive measures to curative approaches. Additionally, it includes meaningful information on the intricate molecular mechanisms underlying the broomrape-host interaction, focusing on the host recognition of parasitic plant molecular patterns and the hormonal crosstalk that regulates the establishment of parasitism. Moreover, this article highlights the potential of breeding for resistance in cultivated crops, such as tomato and faba bean, as a sustainable, long-term solution to combat broomrape infestation. This review serves as a valuable resource for both researchers and farmers, offering insights for developing, implementing, and adapting effective and environmentally sustainable management practices for broomrape in Mediterranean agricultural systems.
{"title":"Broomrapes in Major Mediterranean Crops: From Management Strategies to Novel Approaches for Next-Generation Control.","authors":"Demosthenis Chachalis, Eleni Tani, Aliki Kapazoglou, Maria Gerakari, Angeliki Petraki, Francisco Pérez-Alfocea, Purificación A Martínez-Melgarejo, Markus Albert, Khalil Khamassi, Mohamed Kharrat","doi":"10.3390/biotech14020040","DOIUrl":"10.3390/biotech14020040","url":null,"abstract":"<p><p>Broomrapes (<i>Orobanche</i> and <i>Phelipanche</i> spp.) are parasitic weeds that significantly impact the productivity of major crops in the Mediterranean region, like tomato (<i>Solanum</i> spp.) and faba bean (<i>Vicia faba</i>) species. This review article extensively discusses management strategies to control broomrapes, which range from preventive measures to curative approaches. Additionally, it includes meaningful information on the intricate molecular mechanisms underlying the broomrape-host interaction, focusing on the host recognition of parasitic plant molecular patterns and the hormonal crosstalk that regulates the establishment of parasitism. Moreover, this article highlights the potential of breeding for resistance in cultivated crops, such as tomato and faba bean, as a sustainable, long-term solution to combat broomrape infestation. This review serves as a valuable resource for both researchers and farmers, offering insights for developing, implementing, and adapting effective and environmentally sustainable management practices for broomrape in Mediterranean agricultural systems.</p>","PeriodicalId":34490,"journal":{"name":"BioTech","volume":"14 2","pages":""},"PeriodicalIF":2.7,"publicationDate":"2025-05-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12190798/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144486336","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
As part of the substantial public discourse surrounding the distribution and use of mifepristone, which is used with misoprostol to facilitate drug-induced abortions, claims comparing the safety of this regimen to that of common pharmaceuticals have emerged and proliferated. Offered in forums ranging from social media to the Supreme Court, these claims have so gained public acceptance that they are now echoed without scrutiny and, at times, reference. Yet the simplistic slogan that "mifepristone is safer than Tylenol", though easily disseminated, defies both an intuitive understanding of how we evaluate drug safety and our norms and regulations for doing so. Indeed, if such an assertion was attributable to the manufacturer, it would precipitate a reprimand by the FDA given the lack of specific, controlled, and head-to-head evidence rightly required for its support. To the extent that these claims persist, however, including among the outputs of medical societies, abortion centers, clinical researchers, and government officials, and to the extent that they aim to inform both individual and public decision-making, it is critical that the evidence offered for their support be thoroughly explored. Such examination reveals these claims to be wholly unfounded, offering deficient and disingenuous representations of safety for any of the drugs compared.
{"title":"The Origins and Proliferation of Unfounded Comparisons Regarding the Safety of Mifepristone.","authors":"Cameron Louttit","doi":"10.3390/biotech14020039","DOIUrl":"10.3390/biotech14020039","url":null,"abstract":"<p><p>As part of the substantial public discourse surrounding the distribution and use of mifepristone, which is used with misoprostol to facilitate drug-induced abortions, claims comparing the safety of this regimen to that of common pharmaceuticals have emerged and proliferated. Offered in forums ranging from social media to the Supreme Court, these claims have so gained public acceptance that they are now echoed without scrutiny and, at times, reference. Yet the simplistic slogan that \"mifepristone is safer than Tylenol\", though easily disseminated, defies both an intuitive understanding of how we evaluate drug safety and our norms and regulations for doing so. Indeed, if such an assertion was attributable to the manufacturer, it would precipitate a reprimand by the FDA given the lack of specific, controlled, and head-to-head evidence rightly required for its support. To the extent that these claims persist, however, including among the outputs of medical societies, abortion centers, clinical researchers, and government officials, and to the extent that they aim to inform both individual and public decision-making, it is critical that the evidence offered for their support be thoroughly explored. Such examination reveals these claims to be wholly unfounded, offering deficient and disingenuous representations of safety for any of the drugs compared.</p>","PeriodicalId":34490,"journal":{"name":"BioTech","volume":"14 2","pages":""},"PeriodicalIF":2.7,"publicationDate":"2025-05-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12191252/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144486346","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Paulo Henrique Guilherme Borges, Barbara Gregio, Helena Tiemi Suzukawa, Gislaine Silva-Rodrigues, Emanuella de Castro Andreassa, Isabela Madeira de Castro, Guilherme Bartolomeu-Gonçalves, Emerson José Venancio, Phileno Pinge-Filho, Viviane Monteiro Góes, Celso Vataru Nakamura, Eliandro Reis Tavares, Tatiana de Arruda Campos Brasil de Souza, Sueli Fumie Yamada-Ogatta, Lucy Megumi Yamauchi
This study reports the construction, expression, and purification of synthetic SARS-CoV-2 spike (S) and nucleoprotein (N) containing immunodominant epitopes. The pET28aS_epit construct included epitopes 287-317, 402, 507, 524-598, and 601-640, while the pET28aN_epit construct included residues 42-62, 153-172, and 355-401. Commercial sequences of both proteins were used as controls. The four constructs were expressed using the Escherichia coli BL21(DE3) star strain at 37 °C. The results show that the S protein constructs were insoluble, unlike the N protein constructs. Both recombinant proteins induced immune responses in mice and were recognized by antibodies present in sera from COVID-19-positive and/or SARS-CoV-2-vaccinated humans. No significant differences in immune recognition were observed between our constructs and the commercially available proteins. In conclusion, S_epit and N_epit could be promising starting points for the development of new strategies based on immunological reactions for the control of SARS-CoV-2 infections.
{"title":"Strategy for the Construction of SARS-CoV-2 S and N Recombinant Proteins and Their Immunogenicity Evaluation.","authors":"Paulo Henrique Guilherme Borges, Barbara Gregio, Helena Tiemi Suzukawa, Gislaine Silva-Rodrigues, Emanuella de Castro Andreassa, Isabela Madeira de Castro, Guilherme Bartolomeu-Gonçalves, Emerson José Venancio, Phileno Pinge-Filho, Viviane Monteiro Góes, Celso Vataru Nakamura, Eliandro Reis Tavares, Tatiana de Arruda Campos Brasil de Souza, Sueli Fumie Yamada-Ogatta, Lucy Megumi Yamauchi","doi":"10.3390/biotech14020038","DOIUrl":"10.3390/biotech14020038","url":null,"abstract":"<p><p>This study reports the construction, expression, and purification of synthetic SARS-CoV-2 spike (S) and nucleoprotein (N) containing immunodominant epitopes. The pET28aS_epit construct included epitopes 287-317, 402, 507, 524-598, and 601-640, while the pET28aN_epit construct included residues 42-62, 153-172, and 355-401. Commercial sequences of both proteins were used as controls. The four constructs were expressed using the <i>Escherichia coli</i> BL21(DE3) star strain at 37 °C. The results show that the S protein constructs were insoluble, unlike the N protein constructs. Both recombinant proteins induced immune responses in mice and were recognized by antibodies present in sera from COVID-19-positive and/or SARS-CoV-2-vaccinated humans. No significant differences in immune recognition were observed between our constructs and the commercially available proteins. In conclusion, S_epit and N_epit could be promising starting points for the development of new strategies based on immunological reactions for the control of SARS-CoV-2 infections.</p>","PeriodicalId":34490,"journal":{"name":"BioTech","volume":"14 2","pages":""},"PeriodicalIF":2.7,"publicationDate":"2025-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12191430/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144486345","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}